Sesen Bio (SESN) Announces Significant Commercial Progress as Company Approaches the Potential Approval and Launch of Vicineum in the US

Go back to Sesen Bio (SESN) Announces Significant Commercial Progress as Company Approaches the Potential Approval and Launch of Vicineum in the US
(NASDAQ: SESN) Delayed: 0.96 +0.08 (9.09%)
Previous Close $0.88    52 Week High
Open $0.89    52 Week Low
Day High $1.01    P/E N/A 
Day Low $0.87    EPS
Volume 17,770,519